Business Context and Reporting Period
This Form 6-K filing by MDxHealth SA covers the month of June 2025. The report details the outcomes of the Company's Ordinary Annual General Shareholders' Meeting (AGM) and Extraordinary General Shareholders' Meeting (EGM) held on May 28, 2025, and announces a rescheduled EGM.
Key Corporate Actions
- AGM Outcome: The AGM addressed resolutions for the financial year ended December 31, 2024, and board mandate renewals. Despite no attendance quorum being met, all proposed resolutions were duly passed.
- EGM Rescheduling: The initial EGM failed to meet the required attendance quorum. A new EGM is scheduled for June 27, 2025, at 3:00 p.m. Belgian time in Ghent, Belgium, with no attendance quorum requirement for this second meeting.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance data.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this filing. The primary change is the procedural rescheduling of the EGM to June 27, 2025.
Outlook, Risks, and Unusual Items
- Share Option Plan: The filing references a 2025 Share Option Plan and a related Board Report, which are incorporated by reference from a previous Form 6-K filed on May 2, 2025.
- Legal Status of Exhibits: Exhibits 99.1 through 99.6 are furnished but not deemed "filed" under Section 18 of the Exchange Act and are not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific resolutions passed at the AGM regarding the 2024 financial year and board mandates.
- Confirm the agenda and proposed resolutions for the rescheduled EGM on June 27, 2025.
- Review the 2025 Share Option Plan details referenced in the May 2, 2025 filing.
- Check for subsequent filings containing the audited financial results for the year ended December 31, 2024.